In addition, GSEA analyses revealed remarkable evidence that BDKRB2 expression was particularly correlated with EMT, which had been extensively confirmed to play a key role not only in glioma migration/invasion but also in glioma recurrence and therapeutic resistance [39–41]. Here, BDKRB2 is linked to glioma.